Mike - thanks for the great input. I'm very bullish on AGPH in the 1-2 yr time frame, where they're gaining market share with Viracept over MRK's Crixivan (the leader), having already overtaken the Roche and Abbott compounds for treatment of AIDS. Farther out, not sure. Short term, there are earnings and anticipated announcements, but also week by week fears that the low inflation rate party's bunch bowl may be taken away. Aug 1st AGPH reported earnings that smashed estimates for small losses; the stock was in the low to mid 90s that week, but the annoucement came the same day as bad news in the bond market, and the stock's jump was only about 6%, which quickly dissipated. So once bitten, twice shy. There remains a lot of skepticism regarding AGPH, but I understand drug companies and biotechs, and am bullish going forward. Thus, to me, straight out call purchases, spreads opened at one price and closed at a higher stock price, and rolling up/rolling down on retraces are the strategies I'm thinking about. Any suggestions?
TIA
Randy |
